📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Utrophin correlates with disease severity in Duchenne muscular dystrophy. (2023)

First Author: Guiraud S

Attributed to: Second generation arylhydrocarbon receptor antagonist, utrophin modulators for the treatment of Duchenne muscular dystrophy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.medj.2023.03.005

PubMed Identifier: 37060897

Publication URI: http://europepmc.org/abstract/MED/37060897

Type: Journal Article/Review

Volume: 4

Parent Publication: Med (New York, N.Y.)

Issue: 4

ISSN: 2666-6340